Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,563 | 30,328 | 45,699 | 29,397 | 21,200 |
| Marketable Securities | 222,914 | 223,746 | 215,317 | 241,289 | 260,598 |
| TOTAL | $248,040 | $257,242 | $264,842 | $273,886 | $284,584 |
| Non-Current Assets | |||||
| PPE Net | 1,410 | 1,559 | 1,728 | 1,718 | 1,691 |
| Other Non-Current Assets | 2,643 | 2,828 | 3,012 | 3,189 | 3,368 |
| TOTAL | $4,053 | $4,387 | $4,740 | $4,907 | $5,059 |
| Total Assets | $252,093 | $261,629 | $269,582 | $278,793 | $289,643 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,186 | 1,470 | 1,297 | 1,372 | 1,940 |
| Accrued Expenses | 6,276 | 5,962 | 5,097 | 5,722 | 7,682 |
| TOTAL | $8,462 | $7,432 | $6,394 | $7,094 | $9,622 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,534 | 1,744 | 1,946 | 2,142 | 2,334 |
| TOTAL | $1,534 | $1,744 | $1,946 | $2,142 | $2,334 |
| Total Liabilities | $9,996 | $9,176 | $8,340 | $9,236 | $11,956 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,763 | 56,621 | 56,621 | 56,495 | 56,494 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -227,214 | -213,563 | -200,524 | -188,731 | -177,626 |
| Other shareholders' equity | 475 | 914 | -217 | -167 | 62 |
| TOTAL | $242,097 | $252,453 | $261,242 | $269,557 | $277,687 |
| Total Liabilities And Equity | $252,093 | $261,629 | $269,582 | $278,793 | $289,643 |